Alkermes Plc (ALKS)
30.62
+1.47
(+5.04%)
USD |
NASDAQ |
Jan 14, 16:00
30.62
0.00 (0.00%)
After-Hours: 20:00
Alkermes EPS Diluted (Quarterly): 0.4911 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Avadel Pharmaceuticals Plc | 0.0002 |
| CorMedix, Inc. | 1.259 |
| Jazz Pharmaceuticals Plc | 4.081 |
| Amarin Corp. Plc | -0.3702 |
| Amicus Therapeutics, Inc. | 0.0558 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 82.76M |
| Revenue (Quarterly) | 394.18M |
| Total Expenses (Quarterly) | 311.42M |
| Enterprise Value | 4.016B |
| Gross Profit Margin (Quarterly) | 86.56% |
| Profit Margin (Quarterly) | 21.00% |
| Earnings Yield | 6.60% |
| Operating Earnings Yield | 6.97% |
| Normalized Earnings Yield | 6.612 |